Increased levels of chemokines, CXC11 and CCL18, and VEGFA mRNA levels in cHRPC further confirmed the tumor-supporting role of HRPC towards 92.1UM probably through different molecular strategies, i.e., (i) promoting monocyte chemotaxis [50,54] and (ii) stimulating angiogenesis. This evidence concerns the gene CCL18 and neoplasm.